Related Experiment Video

Updated: Aug 13, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

The future of rotavirus vaccines

Paul A Offit1

  • 1Section of Infectious Diseases, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, USA. offit@email.chop.edu

Seminars in Pediatric Infectious Diseases
|August 30, 2002
PubMed

Insights

A previous rotavirus vaccine was withdrawn due to intussusception risks. New vaccine development requires rigorous safety trials to prevent adverse events like intussusception.

Area of Science:

  • Vaccinology
  • Pediatric Infectious Diseases
  • Gastroenterology

Background:

  • A simian-human reassortant rotavirus vaccine, licensed in 1998, was withdrawn within a year due to an association with intussusception.
  • The incidence was estimated at 1 case per 10,000 immunized children, highlighting a significant safety concern.

Purpose of the Study:

  • To emphasize the critical need for large, prelicensure clinical trials for new rotavirus vaccine development.
  • To discuss the ongoing challenges and considerations for creating safe and effective rotavirus vaccines.

Main Methods:

  • Review of historical vaccine safety data and current clinical trial landscape for rotavirus vaccines.
  • Discussion of etiological and pathogenetic hypotheses for vaccine-associated intussusception.

Main Results:

  • The initial rotavirus vaccine posed an unacceptable risk of intussusception, leading to its withdrawal.
  • Current research focuses on candidate vaccines, including a bovine-human reassortant pentavalent vaccine and an attenuated human rotavirus monovalent vaccine.

Conclusions:

  • Rigorous safety evaluations, including large clinical trials, are essential for the successful development of new rotavirus vaccines.
  • Key considerations for future vaccines include acceptable risk thresholds for intussusception and economic feasibility for global distribution, particularly in developing nations.

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...